Bicky Thapa (@bickythapa02) profile picture
United States
Joined June 2019
RT @DrChoueiri: JUST IN: @FDA approves peri-operative PD-L1 inhibitor Durvalumab + EV in cis-ineligible/refusing Muscle-Invasive Bladder Caโ€ฆ
Clonal evolution. Wheler was here too but she left before the photo. Proud of these mentees and wonderful opportunity to see them at TargetCancer Foundation meeting for rare cancers. ๐Ÿงจ๐Ÿฆ„๐Ÿฆ“๐ŸŽฏ๐Ÿ’ก๐Ÿ‘
1
3
1
33
3,798
โญ๏ธ๐ŸšจNivolumab/Ipilimumab and Pembrolizumab for All Cancers: Australia's Landmark Tumor-Agnostic Immunotherapy Reimbursement | Journal of Clinical Oncology @JCO_ASCO @ASCO @Dr_R_Kurzrock @OncoAlert ascopubs.org/doi/10.1200/JCOโ€ฆ
21
3
45
6,519
Proud to see @NazliDizman @DanaFarber on the main stage at @SWOG in our GU planning session. Grateful to @PBarataMD @caseccc (PI of S2419, BIOFRONT) & @BraunMDPhD @YaleCancer (GU translational lead) for getting her involved in analyzing biomarker results in the 1st P3 study evaluating microbiome modulation to improve IO-outcomes!
1
19
80
2,897
Such an honor to co-chair the WIN symposium with Wafik El Deiry
Bringing the Global Precision Oncology Community Together at WIN Symposium 2026 - Vivek Subbiah, MD @VivekSubbiah @weldeiry @Dr_R_Kurzrock oncodaily.com/voices/vivek-sโ€ฆ
5
14
897
Living the WIN conference. Molecular Tumor Boards everywhere. Who knew that when we coined the term and concept in 2014, it would take off Iike wild fire!!
๐Ÿค– Made with AI
2
5
29
1,038
Bicky Thapa retweeted
Congratulations to my good friend and colleague Mary-Ellen Taplin on the well deserved @PCFnews Women in Science Lifetime Achievement Award ! Thank you @PCF_Science for this important recognition! @DanaFarber_GU @DanaFarber @DanaFarberNews @harvardmed
13
1
61
3,167
๐Ÿšจโญ๏ธWhat an energizing LIVE molecular tumor board at the WIN Symposium , Providence, RI @WIN_Consortium worldโ€‘class precision oncology faculty tackling real & challenging cases in real time @Dr_R_Kurzrock @weldeiry @bickythapa02 @SewantiLimaye โญ๏ธImagine if every patient everywhere had access to this level of expert discussion & insight @OncoAlert @oncodaily
2
9
2
28
2,593
JUST IN: @FDA approves the combo of Lenvatinib+HIF2 inhibitor Belzutifan in advanced clear cell renal cell carcinoma following PD1/L1 inhibitor. Results based on Litespark-011 trial led by @motzermd @DrDanielHeng @SchmidigerManu1 @ASCO @myESMO @AACR @kidneycan @DanaFarber_GU @OncoAlert
47
5
101
6,891
Dr @RashadNawfal is an outstanding prospect for internal medicine residency. He is a superb physician and under his belt he has multi-year laboratory experience in liquid biopsies and epigenomics from my lab and the Freedman lab @DanaFarber @DanaFarber_GU
Hello #MedTwitter #MedX! Iโ€™m Rashad Nawfal, an #IMG from @LebaneseUni and a postdoctoral research fellow at @DanaFarber @harvardmed studying novel liquid biopsy tools for cancer epigenomics. Excited to apply to #InternalMedicine for #Match2027! AAMC ID: 15006561 #InsideTheMatch
2
6
49
8,402
Iโ€™m excited to join fellow experts and Shirley @leung at @BostonGlobe Mediaโ€™s Future of Medicine Summit to discuss how cancer vaccines are rewriting the rules of treatment โ€“ exploring how personalized mRNA vaccines are moving from moonshot ideas to real clinical trials with real patients and real benefits! Join us on September 15 for a day of thought-provoking conversations about whatโ€™s next in healthcare. Learn more and register at Globe.com/futureofmedicine. #FutureofMed2026 @DanaFarber @DanaFarber_GU @DanaFarberNews @OnlyInBOS @ScienceinBoston @harvardmed @TheVinodLab #MichelleBrown
4
18
1
56
4,552
Bicky Thapa retweeted
So thrilled to have you @neerajaiims with us at @DanaFarber! We are incredibly fortunate to welcome not only an outstanding prostate cancer oncologist, but also a terrific colleague and leader. Excited to see all that you will bring to our team and to the @Harvard Cancer Consortium #ProstateCancer Program. Welcome to @CityOfBoston and to the family! @DanaFarber_GU @harvardmed @DanaFarberNews @df_hcc
Thrilled to have joined @DanaFarber and to be working with an inspiring leader in oncology, @DrChoueiri. Delighted to serve as a faculty medical oncologist and Co-Director of the @Harvard Cancer Consortium #ProstateCancer Program. Excited for this new chapter!
13
81
5,881
Bicky Thapa retweeted
Very excited to welcome four outstanding new faculty to the Lank Center for Genitourinary Oncology @DanaFarber 1) Dr. Nazli Dizman @NazliDizman 2) Dr. Brian Russell @brian_russell39 3) Dr. Hamid Emamekhoo @HamidEmamekhoo 4) Pr. Neeraj Agarwal @neerajaiims They bring complementary expertise spanning clinical investigation, microbiome science, informatics, quality improvement, education, and GU oncology. Hamid and Neeraj will also take on important broader institutional leadership roles @DanaFarber and @Harvard Cancer Consortium @df_hcc We are fortunate to have themโ€”and the @DanaFarber_GU and our patients are in very good hands. Welcome to @CityOfBoston and @DanaFarber!
15
23
2
213
11,309
Have you ever wondered what takes place in a TCF-001 TRACK Virtual #MolecularTumorBoard meeting? Watch to learn how biomarker testing and multi-disciplinary expertise come together to uncover treatment options for difficult-to-treat #RareCancers targetcancer.short.gy/RCTT-2โ€ฆ
1
2
1
3
2,326
๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜: bit.ly/WINSympo2026website Program spotlight: ๐—ช๐—œ๐—ก ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐— ๐—ผ๐—น๐—ฒ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ง๐˜‚๐—บ๐—ผ๐—ฟ ๐—•๐—ผ๐—ฎ๐—ฟ๐—ฑ At ๐—ช๐—œ๐—ก ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, the WIN International Molecular Tumor Board will bring together multidisciplinary international experts for live case discussions from ๐—ช๐—œ๐—ก ๐—–๐—ผ๐—ป๐˜€๐—ผ๐—ฟ๐˜๐—ถ๐˜‚๐—บ institutions, with audience participation encouraged. The tumor board will be chaired by ๐——๐—ฟ. ๐—ฅ๐—ฎ๐˜‡๐—ฒ๐—น๐—น๐—ฒ ๐—ž๐˜‚๐—ฟ๐˜‡๐—ฟ๐—ผ๐—ฐ๐—ธ, ๐— ๐——, ๐—™๐—”๐—–๐—ฃ, WIN Consortium, Chevilly-Larue, France, and Medical College of Wisconsin, Milwaukee, WI, USA. Co-chairs include ๐——๐—ฟ. ๐—ช๐—ฎ๐—ณ๐—ถ๐—ธ ๐—˜๐—น-๐——๐—ฒ๐—ถ๐—ฟ๐˜†, ๐— ๐——, ๐—ฃ๐—ต๐——, ๐—™๐—”๐—–๐—ฃ, WIN Consortium, Chevilly-Larue, France, and Brown University Health, Providence, RI, USA; and ๐——๐—ฟ. ๐—ฆ๐—ฒ๐˜„๐—ฎ๐—ป๐˜๐—ถ ๐—”. ๐—Ÿ๐—ถ๐—บ๐—ฎ๐˜†๐—ฒ, ๐— ๐—•๐—•๐—ฆ, ๐— ๐——, ๐— ๐—ฆ, WIN Consortium, Chevilly-Larue, France, and Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai, India. Panelists include ๐——๐—ฟ. ๐—š๐—ถ๐˜‚๐˜€๐—ฒ๐—ฝ๐—ฝ๐—ฒ ๐—–๐˜‚๐—ฟ๐—ถ๐—ด๐—น๐—ถ๐—ฎ๐—ป๐—ผ, ๐— ๐——, ๐—ฃ๐—ต๐——; ๐——๐—ฟ. ๐—ฉ๐—ถ๐˜ƒ๐—ฒ๐—ธ ๐—ฆ๐˜‚๐—ฏ๐—ฏ๐—ถ๐—ฎ๐—ต, ๐— ๐——; ๐——๐—ฟ. ๐—š๐—ถ๐˜€๐—ฒ๐—น๐—น๐—ฒ ๐—Ÿ. ๐—ฆ๐—ฎ๐˜‚๐—น๐—ป๐—ถ๐—ฒ๐—ฟ ๐—ฆ๐—ต๐—ผ๐—น๐—น๐—ฒ๐—ฟ, ๐— ๐——; ๐—ฎ๐—ป๐—ฑ ๐——๐—ฟ. ๐—•๐—ถ๐—ฐ๐—ธ๐˜† ๐—ง๐—ต๐—ฎ๐—ฝ๐—ฎ, ๐— ๐——, ๐— ๐—ฆ, ๐—™๐—”๐—–๐—ฃ. ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป ๐—ฐ๐—น๐—ผ๐˜€๐—ฒ๐˜€ ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. Register now and submit your abstract by the deadline. WIN Symposium 2026, ๐—ฒ๐—ป๐—ฑ๐—ผ๐—ฟ๐˜€๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—”๐—ฆ๐—–๐—ขยฎ, will take place ๐—ข๐—ฐ๐˜๐—ผ๐—ฏ๐—ฒ๐—ฟ ๐Ÿฎ-๐Ÿฏ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ, ๐—ฅ๐—ต๐—ผ๐—ฑ๐—ฒ ๐—œ๐˜€๐—น๐—ฎ๐—ป๐—ฑ, ๐—จ๐—ฆ๐—”. #WINSympo2026 #PrecisionOncology #CancerResearch #Oncology #MolecularTumorBoard ASCOยฎ and American Society of Clinical Oncologyยฎ are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.
3
1
5
2,100
๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜: bit.ly/WINSympo2026website ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—•๐—ถ๐—ฟ๐—ฑ ๐—ฟ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป for ๐—ช๐—œ๐—ก ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ closes on ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿญ๐Ÿฒ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป has been extended to ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. Explore ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜†. This session will highlight translational research, clinical trial design, novel therapies and the application of precision oncology across cancer types. Session speakers include: > ๐——๐—ฟ. ๐—š๐—ถ๐˜‚๐˜€๐—ฒ๐—ฝ๐—ฝ๐—ฒ ๐—–๐˜‚๐—ฟ๐—ถ๐—ด๐—น๐—ถ๐—ฎ๐—ป๐—ผ, ๐— ๐——, ๐—ฃ๐—ต๐—— University of Milano / European Institute of Oncology, Milan, Italy | President-Elect, ESMO 2027-2028 > ๐——๐—ฟ. ๐—•๐—ฒ๐—ป๐—ฒ๐—ฑ๐—ถ๐˜๐—ผ ๐—”. ๐—–๐—ฎ๐—ฟ๐—ป๐—ฒ๐—ถ๐—ฟ๐—ผ, ๐— ๐——, ๐— ๐—ฆ Legorreta Cancer Center, Brown University, Providence, RI, USA > ๐——๐—ฟ. ๐—๐—ฒ๐—ป๐—ป๐—ถ๐—ณ๐—ฒ๐—ฟ ๐—š๐—ฟ๐—ฎ๐—ป๐—ฑ๐—ถ๐˜€, ๐— ๐—— University of California San Francisco, San Francisco, CA, USA > ๐——๐—ฟ. ๐—ž๐—ผ๐—ฟ๐—ป๐—ฒ๐—น๐—ถ๐—ฎ ๐—ฃ๐—ผ๐—น๐˜†๐—ฎ๐—ธ, ๐— ๐——, ๐—ฃ๐—ต๐—— Harvard Medical School / Dana-Farber Cancer Institute, Boston, MA, USA ๐—ช๐—œ๐—ก ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ is endorsed by ASCOยฎ*, supporting the scientific positioning of this yearโ€™s program. ๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฏ๐˜† ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿญ๐Ÿฒ ๐˜๐—ผ ๐˜€๐—ฒ๐—ฐ๐˜‚๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—•๐—ถ๐—ฟ๐—ฑ ๐—ฟ๐—ฎ๐˜๐—ฒ. ๐—ฆ๐˜‚๐—ฏ๐—บ๐—ถ๐˜ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฝ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—ฏ๐˜† ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ. #WINSympo2026 #PrecisionOncology #CancerResearch #Oncology #ClinicalResearch *ASCOยฎ and American Society of Clinical Oncologyยฎ are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.
3
1
4
1,396
Breathtaking line up including Nobel Laureate. And Rhode Island is stunning
๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜: bit.ly/WINSympo2026website ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—•๐—ถ๐—ฟ๐—ฑ ๐—ฟ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป for ๐—ช๐—œ๐—ก ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ closes on ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿญ๐Ÿฒ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป has been extended to ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. Explore ๐—™๐—ฟ๐—ผ๐—บ ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐˜๐—ผ ๐——๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜† - ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ง๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฎ๐—ป๐—ฑ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป. This session will examine how precision oncology is moving from molecular insight to clinical delivery, with discussion spanning molecular profiling, N-of-1 oncology, bedside-to-bench translational research, rational combination therapies and regulatory innovation. Session speakers include: > ๐——๐—ฟ. ๐—ฅ๐—ฎ๐˜‡๐—ฒ๐—น๐—น๐—ฒ ๐—ž๐˜‚๐—ฟ๐˜‡๐—ฟ๐—ผ๐—ฐ๐—ธ, ๐— ๐——, ๐—™๐—”๐—–๐—ฃ WIN Consortium, Chevilly-Larue, France & Medical College of Wisconsin, Milwaukee, WI, USA > ๐——๐—ฟ. ๐—ž๐—ฒ๐—ถ๐˜๐—ต ๐—ง. ๐—™๐—น๐—ฎ๐—ต๐—ฒ๐—ฟ๐˜๐˜†, ๐— ๐——, ๐—™๐—”๐—”๐—–๐—ฅ Massachusetts General Hospital / Harvard Medical School, USA | AACR President, Boston, MA, USA > ๐——๐—ฟ. ๐—ฅ๐—ถ๐—ฐ๐—ต๐—ฎ๐—ฟ๐—ฑ ๐—ฃ๐—ฎ๐˜‡๐—ฑ๐˜‚๐—ฟ, ๐— ๐—— Former Director, FDA Oncology Center of Excellence, Washington, USA Chaired by ๐——๐—ฟ. ๐—ฅ๐—ฎ๐˜‡๐—ฒ๐—น๐—น๐—ฒ ๐—ž๐˜‚๐—ฟ๐˜‡๐—ฟ๐—ผ๐—ฐ๐—ธ, ๐— ๐——, ๐—™๐—”๐—–๐—ฃ and ๐——๐—ฟ. ๐—ช๐—ฎ๐—ณ๐—ถ๐—ธ ๐—ฆ. ๐—˜๐—น-๐——๐—ฒ๐—ถ๐—ฟ๐˜†, ๐— ๐——, ๐—ฃ๐—ต๐——, ๐—™๐—”๐—–๐—ฃ. WIN Symposium 2026 is endorsed by American Society Of Clinical Oncologyยฎ*, supporting the scientific positioning of this yearโ€™s program. ๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฏ๐˜† ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿญ๐Ÿฒ ๐˜๐—ผ ๐˜€๐—ฒ๐—ฐ๐˜‚๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—•๐—ถ๐—ฟ๐—ฑ ๐—ฟ๐—ฎ๐˜๐—ฒ. ๐—ฆ๐˜‚๐—ฏ๐—บ๐—ถ๐˜ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฝ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—ฏ๐˜† ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ. #WINSympo2026 #PrecisionOncology #CancerResearch #Oncology #TranslationalResearch *ASCOยฎ and American Society of Clinical Oncologyยฎ are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.
3
11
1,859
๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ป๐—ฑ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜: bit.ly/WINSympo2026website ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—•๐—ถ๐—ฟ๐—ฑ ๐—ฟ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป for ๐—ช๐—œ๐—ก ๐—ฆ๐˜†๐—บ๐—ฝ๐—ผ๐˜€๐—ถ๐˜‚๐—บ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ closes on ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿญ๐Ÿฒ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป has been extended to ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ, ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ. Explore ๐—™๐—ฟ๐—ผ๐—บ ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐˜๐—ผ ๐——๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜† - ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ง๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ฎ๐—ป๐—ฑ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป. This session will examine how precision oncology is moving from molecular insight to clinical delivery, with discussion spanning molecular profiling, N-of-1 oncology, bedside-to-bench translational research, rational combination therapies and regulatory innovation. Session speakers include: > ๐——๐—ฟ. ๐—ฅ๐—ฎ๐˜‡๐—ฒ๐—น๐—น๐—ฒ ๐—ž๐˜‚๐—ฟ๐˜‡๐—ฟ๐—ผ๐—ฐ๐—ธ, ๐— ๐——, ๐—™๐—”๐—–๐—ฃ WIN Consortium, Chevilly-Larue, France & Medical College of Wisconsin, Milwaukee, WI, USA > ๐——๐—ฟ. ๐—ž๐—ฒ๐—ถ๐˜๐—ต ๐—ง. ๐—™๐—น๐—ฎ๐—ต๐—ฒ๐—ฟ๐˜๐˜†, ๐— ๐——, ๐—™๐—”๐—”๐—–๐—ฅ Massachusetts General Hospital / Harvard Medical School, USA | AACR President, Boston, MA, USA > ๐——๐—ฟ. ๐—ฅ๐—ถ๐—ฐ๐—ต๐—ฎ๐—ฟ๐—ฑ ๐—ฃ๐—ฎ๐˜‡๐—ฑ๐˜‚๐—ฟ, ๐— ๐—— Former Director, FDA Oncology Center of Excellence, Washington, USA Chaired by ๐——๐—ฟ. ๐—ฅ๐—ฎ๐˜‡๐—ฒ๐—น๐—น๐—ฒ ๐—ž๐˜‚๐—ฟ๐˜‡๐—ฟ๐—ผ๐—ฐ๐—ธ, ๐— ๐——, ๐—™๐—”๐—–๐—ฃ and ๐——๐—ฟ. ๐—ช๐—ฎ๐—ณ๐—ถ๐—ธ ๐—ฆ. ๐—˜๐—น-๐——๐—ฒ๐—ถ๐—ฟ๐˜†, ๐— ๐——, ๐—ฃ๐—ต๐——, ๐—™๐—”๐—–๐—ฃ. WIN Symposium 2026 is endorsed by American Society Of Clinical Oncologyยฎ*, supporting the scientific positioning of this yearโ€™s program. ๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฏ๐˜† ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿญ๐Ÿฒ ๐˜๐—ผ ๐˜€๐—ฒ๐—ฐ๐˜‚๐—ฟ๐—ฒ ๐˜๐—ต๐—ฒ ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—•๐—ถ๐—ฟ๐—ฑ ๐—ฟ๐—ฎ๐˜๐—ฒ. ๐—ฆ๐˜‚๐—ฏ๐—บ๐—ถ๐˜ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฝ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—ฏ๐˜† ๐—”๐˜‚๐—ด๐˜‚๐˜€๐˜ ๐Ÿฎ๐Ÿญ. #WINSympo2026 #PrecisionOncology #CancerResearch #Oncology #TranslationalResearch *ASCOยฎ and American Society of Clinical Oncologyยฎ are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.
3
1
5
2,161